4.7 Article

Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer's Disease

期刊

BIOMEDICINES
卷 9, 期 12, 页码 -

出版社

MDPI
DOI: 10.3390/biomedicines9121910

关键词

Alzheimer's disease; senile plaques; beta-amyloid protein; tau protein; diagnosis; biomarker; treatment; acetylcholinesterase inhibitors; immunotherapy

资金

  1. Junta de Andalucia, Spain [P20-01293, PECART-0096-2020]
  2. Ministry of Science and Innovation, Spain [PID2020-117544RB-100]

向作者/读者索取更多资源

Alzheimer's disease is characterized by cognitive decline and memory loss, with the amyloid cascade hypothesis being the leading theory in its pathophysiology. Diagnosis is currently based on clinical parameters and fluid-based biomarkers, with treatment focusing on symptom control through pharmacological and nonpharmacological approaches. Further research is needed to identify new biomarkers and therapies to prevent progression of the disease.
Alzheimer's disease (AD) is the most common cause of dementia. It is characterized by cognitive decline and progressive memory loss. The aim of this review was to update the state of knowledge on the pathophysiological mechanisms, diagnostic methods and therapeutic approach to AD. Currently, the amyloid cascade hypothesis remains the leading theory in the pathophysiology of AD. This hypothesis states that amyloid-beta (A beta) deposition triggers a chemical cascade of events leading to the development of AD dementia. The antemortem diagnosis of AD is still based on clinical parameters. Diagnostic procedures in AD include fluid-based biomarkers such as those present in cerebrospinal fluid and plasma or diagnostic imaging methods. Currently, the therapeutic armory available focuses on symptom control and is based on four pillars: pharmacological treatment where acetylcholinesterase inhibitors stand out; pharmacological treatment under investigation which includes drugs focused on the control of A beta pathology and tau hyperphosphorylation; treatment focusing on risk factors such as diabetes; or nonpharmacological treatments aimed at preventing development of the disease or treating symptoms through occupational therapy or psychological help. AD remains a largely unknown disease. Further research is needed to identify new biomarkers and therapies that can prevent progression of the pathology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据